Episode
Episode 193: Intensive BP lowering, elinzanetant for VMS, HTN in pregnancy and prostate CA screening
- Podcast
- Primary Care Update
- Published
- Nov 12, 2025
- Duration seconds
- 2292
- Processing state
not_requested
Actions
POST https://stenobird.com/v1/public/podcasts/primary-care-update-1000928/episodes/episode-193-intensive-bp-lowering-elinzanetant-for-vms-htn-in-pregnancy-and-prostate-ca-screening/transcription-requests
Idempotently request low-priority transcript generation for this episode.GET https://stenobird.com/podcast/primary-care-update-1000928/episode-193-intensive-bp-lowering-elinzanetant-for-vms-htn-in-pregnancy-and-prostate-ca-screening.md
Read the agent-friendly Markdown representation of this episode resource.
Summary
Primary care physicians Gary Ferenchick, Kate Rowland, Henry Barry and Mark Ebell want you to know about 4 new studies: the best choice of pharmacotherapy in hypertensive disorders of pregnancy, benefits and harms of intensive BP lowering, elinzanetant for therapy-induced vasomotor symptoms in women with breast cancer, and 23 year follow up of the European Prostate Cancer Screening Trial. Plus a confusing quiz question (thanks Gary!). Links Essential Evidence Plus: www.essentialevidenceplus.com HTN in pregnancy: https://pubmed.ncbi.nlm.nih.gov/40216176/ Intensive BP lowering: https://pubmed.ncbi.nlm.nih.gov/40902616/ Elinzanetant for vasomotor symptoms in patients taking tamoxifen or anastrozole: https://pubmed.ncbi.nlm.nih.gov/40454634/ 23 year follow-up of large European prostate cancer study: https://pubmed.ncbi.nlm.nih.gov/41160819/